Analyze Diet
Biochimica et biophysica acta1986; 854(1); 93-101; doi: 10.1016/0005-2736(86)90068-4

Cytolytic activity of liposomes containing stearylamine.

Abstract: In order to develop the cytotoxic liposome, the cytolytic effect of polycationic liposome was examined. Upon incubation of the stearylamine-containing liposome (stearylamine-liposome) with rabbit erythrocyte, a significant extent of hemolysis was observed. Hemolytic activity of the liposome depends on the amount of stearylamine in the liposome membrane. The plots of the initial rate of hemolysis versus the concentration of stearylamine-liposome showed a sigmoidal curve, suggesting that stearylamine-liposomes act cooperatively on the erythrocyte membrane. Hemolytic activity of stearylamine-liposome was markedly influenced by the composition of hydrocarbon chains of the phospholipids in the liposome membrane, suggesting that the membrane fluidity of stearylamine-liposome is important to evoke the hemolysis. Since the liposomes containing acidic phospholipids inhibited markedly the stearylamine-liposome-caused hemolysis, it is likely that the primary target of stearylamine-liposome is the negatively charged component(s) such as acidic phospholipids on the erythrocyte membrane. Furthermore, stearylamine-liposome induced the release of the intravesicular contents from the liposome made of acidic phospholipids but not from the liposome made of phosphatidylcholine only. These results suggest that stearylamine-liposome interacted with the negative charges of the erythrocyte membrane and eventually damaged the cell. Erythrocytes from rabbit, horse and guinea pig are highly susceptible to stearylamine-liposome but those from man, sheep, cow and chicken are less so.
Publication Date: 1986-01-16 PubMed ID: 3942721DOI: 10.1016/0005-2736(86)90068-4Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers are finding out more about the cytolysis effects of liposomes (tiny bubble-like structures used in drug delivery) containing stearylamine, an ingredient that shows promise in developing cytotoxic liposomes for cancer treatment.

Objective

  • The aim of the study is to analyze and understand the cytolytic effect of liposomes containing stearylamine, which could aid in the creation of more effective cytotoxic liposomes for cancer treatment. One of the main goals was to examine the hemolytic (red blood cell destruction) activity of these liposomes.

Methodology

  • The researchers incubated stearylamine-liposomes with rabbit erythrocytes (red blood cells). The amount of hemolysis observed was measured and analyzed.
  • To better understand the influence of stearylamine, the research team scrutinized the relationship between its concentration in the liposome membrane and its hemolytic activity.

Findings

  • An increase in the concentration of stearylamine-liposome led to an increased initial rate of hemolysis, depicted in a sigmoidal curve. It implied that these liposomes act cooperatively on the erythrocyte membrane to instigate the hemolysis.
  • The composition of hydrocarbon chains in the liposome membrane plays a significant role in the hemolytic activity of stearylamine-liposome. This implies that membrane fluidity is a key factor in provoking hemolysis.
  • Liposomes containing acidic phospholipids notably impeded hemolysis caused by stearylamine-liposome, suggesting that stearylamine-liposomes primarily target and act upon negatively charged components of the erythrocyte membrane such as acidic phospholipids.
  • Stearylamine-liposomes could induce release of contents from liposomes made of acidic phospholipids but not from those made solely of phosphatidylcholine. This further validates the idea of negative charges on erythrocyte membrane being the main target.

Conclusion

  • The study shows that the action of stearylamine-liposome could cause damage to erythrocytes through their interaction and eventually destroying the cells.
  • The susceptibility to stearylamine-liposome varied across species, with erythrocytes from rabbits, horses, and guinea pigs showing high susceptibility, while those from humans, sheep, cows, and chickens exhibited lesser susceptibility.

Cite This Article

APA
Yoshihara E, Nakae T. (1986). Cytolytic activity of liposomes containing stearylamine. Biochim Biophys Acta, 854(1), 93-101. https://doi.org/10.1016/0005-2736(86)90068-4

Publication

ISSN: 0006-3002
NlmUniqueID: 0217513
Country: Netherlands
Language: English
Volume: 854
Issue: 1
Pages: 93-101

Researcher Affiliations

Yoshihara, E
    Nakae, T

      MeSH Terms

      • Amines
      • Animals
      • Cattle
      • Chickens
      • Erythrocytes
      • Fatty Acids / physiology
      • Fluoresceins
      • Guinea Pigs
      • Hemolysis
      • Horses
      • Humans
      • Hydrogen-Ion Concentration
      • Liposomes
      • Membrane Fluidity
      • Phosphatidylserines / physiology
      • Phospholipids / physiology
      • Rabbits
      • Sheep
      • Species Specificity

      Citations

      This article has been cited 12 times.
      1. Sriwidodo, Umar AK, Wathoni N, Zothantluanga JH, Das S, Luckanagul JA. Liposome-polymer complex for drug delivery system and vaccine stabilization. Heliyon 2022 Feb;8(2):e08934.
        doi: 10.1016/j.heliyon.2022.e08934pubmed: 35243059google scholar: lookup
      2. Suyamud C, Phetdee C, Jaimalai T, Prangkio P. Silk Fibroin-Coated Liposomes as Biomimetic Nanocarrier for Long-Term Release Delivery System in Cancer Therapy. Molecules 2021 Aug 15;26(16).
        doi: 10.3390/molecules26164936pubmed: 34443524google scholar: lookup
      3. Souto EB, Dias-Ferreira J, Craveiro SA, Severino P, Sanchez-Lopez E, Garcia ML, Silva AM, Souto SB, Mahant S. Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems. Pathogens 2019 Aug 1;8(3).
        doi: 10.3390/pathogens8030119pubmed: 31374930google scholar: lookup
      4. De M, Ghosh S, Sen T, Shadab M, Banerjee I, Basu S, Ali N. A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes. Mol Ther Nucleic Acids 2018 Mar 2;10:9-27.
        doi: 10.1016/j.omtn.2017.10.019pubmed: 29499959google scholar: lookup
      5. Rajendran V, Rohra S, Raza M, Hasan GM, Dutt S, Ghosh PC. Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria. Antimicrob Agents Chemother 2015 Dec 14;60(3):1304-18.
        doi: 10.1128/AAC.01796-15pubmed: 26666937google scholar: lookup
      6. Mattheolabakis G, Nie T, Constantinides PP, Rigas B. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation. Pharm Res 2012 Jun;29(6):1435-43.
        doi: 10.1007/s11095-011-0619-ypubmed: 22072052google scholar: lookup
      7. al-Suwayeh SA, Tebbett IR, Wielbo D, Brazeau GA. In vitro-in vivo myotoxicity of intramuscular liposomal formulations. Pharm Res 1996 Sep;13(9):1384-8.
        doi: 10.1023/a:1016082218942pubmed: 8893279google scholar: lookup
      8. Lappalainen K, Jääskeläinen I, Syrjänen K, Urtti A, Syrjänen S. Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res 1994 Aug;11(8):1127-31.
        doi: 10.1023/a:1018932714745pubmed: 7971713google scholar: lookup
      9. Parthasarathy R, Sacks PG, Harris D, Brock H, Mehta K. Interaction of liposome-associated all-trans-retinoic acid with squamous carcinoma cells. Cancer Chemother Pharmacol 1994;34(6):527-34.
        doi: 10.1007/BF00685666pubmed: 7923565google scholar: lookup
      10. Tachibana H, Yoshihara E, Kaneda Y, Nakae T. In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes. Antimicrob Agents Chemother 1988 Jul;32(7):966-70.
        doi: 10.1128/AAC.32.7.966pubmed: 3056249google scholar: lookup
      11. Huang R, Zhang F, Wang X, Yang F, Ma C. Proteomic Profiling in Pediococcus pentosaceus SF11 Exposed to Condensed Tannins from Sainfoin. ACS Omega 2024 Oct 8;9(40):41148-41156.
        doi: 10.1021/acsomega.3c08947pubmed: 39398120google scholar: lookup
      12. Hussain A, Altamimi MA, Alneef YS. HSPiP and QbD oriented optimized stearylamine-elastic liposomes for topical delivery of ketoconazole to treat deep seated fungal infections: In vitro and ex vivo evaluations. Int J Pharm X 2024 Dec;8:100279.
        doi: 10.1016/j.ijpx.2024.100279pubmed: 39282055google scholar: lookup